Health
Moderna COVID-19 vaccine successful against emerging variants – European Pharmaceutical Review
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Posted: 27 January 2021 | Victoria Rees (European Pharmaceutical Review) | No comments yet
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Moderna has announced results from in vitro neutralisation studies of sera from individuals vaccinated with the company’s COVID-19 vaccine showing activity against emerging strains of SARS-CoV-2.
According to the company, vaccination with the Moderna COVID-19 vaccine…
Continue Reading
